Navigation Links
Bionovo Announces 2009 Highlights and Year-End Financial Results
Date:3/15/2010

ntial pharmacological uses. In addition, our studies have indicated that these compounds do not promote breast or endometrial cancer in animal models, unlike estrogen therapies. This suggests that these ER beta-selective compounds could lead to safer, more appealing therapies for menopausal disorders.
  • Publication of final study results from our Phase 1B trial of Bezielle for metastatic breast cancer. Bezielle showed an excellent safety and tolerability profile. It also showed promising early efficacy in a difficult-to-treat population, including stable disease and tumor regression.
  • International presentation of final study results from our Phase 2 trial of Menerba for menopausal vasomotor symptom treatment. These results included:
    • After 12 weeks of treatment, there was a statistically significant decrease in frequency of all hot flashes in the higher dose of Menerba (p=0.04).
    • There was a clear dose response trend in multiple efficacy analyses.
    • Menerba reduced the number of times women were awakened from sleep due to hot flashes (night sweats). The median percent reduction in night sweats in the higher dose of Menerba was 67%, statistically superior to placebo (p=0.05).
    • Compliance and study retention was excellent: 98% of participants completed the trial, with 91% of participants taking at least 75% of the assigned study medication.
    • The only statistically significant adverse event was "transient loose stools" (12% on Menerba vs. 3% on placebo).
    • During the trial, there was no difference in the number of uterine bleeding episodes between the treatment g
      '/>"/>

    SOURCE Bionovo, Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15

    Related medicine technology :

    1. Bionovo, Inc. to Announce Fourth Quarter and Fiscal Year 2009 Financial Results on Monday, March 15, 2010
    2. Bionovo Announces Publication of Positive Results From the Phase 1B Clinical Trial of Bezielle (BZL101) for Metastatic Breast Cancer
    3. Bionovo Announces Third Quarter 2009 Highlights and Financial Results
    4. Bionovo, Inc. to Announce Third Quarter Fiscal Year 2009 Financial Results on Thursday, November 5, 2009
    5. Bionovo Announces Publication of Data on Potential Increase in Breast Cancer Risk Due to the Inhibitory Effect of Tamoxifen Treatment on Estrogen Receptor Beta
    6. Bionovo Announces Second Quarter 2009 Highlights and Financial Results
    7. Bionovos Estrogen Receptor Beta Selective Drugs Have Unique Gene Expression and Cell Type Specificity
    8. Bionovo Announces First Quarter 2009 Highlights and Financial Results
    9. Bionovo Announces Development Plans for Menopausal Hot Flash Drug Candidate, Menerba (MF101), Following FDA Meetings
    10. Bionovo Presents Positive Results from Phase 1B Trial of BZL101 for Metastatic Breast Cancer at the Society for Integrative Oncology
    11. Bionovo Advances BZL101 to Phase 2 Clinical Trials After Positive Phase 1 Results for Metastatic Breast Cancer
  • Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:8/28/2015)... SEOUL, South Korea , Aug. 28, 2015 /PRNewswire/ ... Chungbuk National University and Dr. Ra from Biostar ... , Confirmed 30% increase of lifespan through multiple ... cognitive function, physical vitality, and life expectancy found ... Researchers in Korea have determined the possibility that adult ...
    (Date:8/27/2015)... , Aug. 27, 2015  The Academy of ... and Drug Administration,s (FDA,s) draft guidance and proposed ... and biosimilars, to bear a nonproprietary name with ... been seeking a decision from the FDA on ... health care stakeholders urging the agency to use ...
    (Date:8/27/2015)... -- According to a new market research report "Medical ... Bariatric ), Material (Nylon, Padded, Canvas), Usage Type (Disposable, Reusable), End ... the Medical Lifting Sling Market is poised to reach USD 706.0 ... CAGR of 11.4 % from 2015 to 2020. ... T ables and 65 F ...
    Breaking Medicine Technology:Korean Researchers Find the Possibility that Adult Mesenchymal Stem Cells (MSCs) May Extend Lifespan 2AMCP Is Disappointed in FDA's Draft Guidance and Proposed Rule Calling for Suffix on Nonproprietary Names of Biological Products 2Medical Lifting Sling Market Worth USD 706.0 Million by 2020 2Medical Lifting Sling Market Worth USD 706.0 Million by 2020 3Medical Lifting Sling Market Worth USD 706.0 Million by 2020 4
    ... 2011 Hurricane Irene came rushing up the East Coast as ... the United States, many states in the Northeast began to worry. ... to hurricanes. Coastal towns from New Jersey all the way up ... York City was one that took steps that had not been ...
    ... DIEGO, Aug. 30, 2011 ADVENTRX Pharmaceuticals, Inc. (NYSE ... on its planned meetings with the U.S. Food and ... Exelbine (vinorelbine injectable emulsion) Type ... is to discuss the complete response letter regarding the ...
    Cached Medicine Technology:Hospitals Evacuated in Preparation for Hurricane Irene with Aid of Pulse Oximeter 2ADVENTRX Provides Update on All Three Pipeline Products 2ADVENTRX Provides Update on All Three Pipeline Products 3ADVENTRX Provides Update on All Three Pipeline Products 4
    (Date:8/28/2015)... ... August 28, 2015 , ... Medical Solutions, one of the nation’s largest travel ... in Healthcare by Modern Healthcare and will be honored at an awards dinner ... year, the Best Places to Work in Healthcare program recognizes outstanding employers in the ...
    (Date:8/28/2015)... ... ... The Quatela Center for Plastic Surgery is excited to bring patients the ground ... the Food and Drug Administration to eliminate submental fat, also known as the double ... among the premier cosmetic surgeons in Rochester to offer this innovative procedure.     , Developed ...
    (Date:8/28/2015)... ... 2015 , ... The Louis W. Sullivan Institute for ... transform quality and efficiency of healthcare delivery worldwide, announced the release of a ... being publicly shared to document progress and inform policy in a report issued ...
    (Date:8/28/2015)... ... August 28, 2015 , ... External Counterpulsation, also known as ECP ... now selling External Counterpulsation (EECP or ECP) machines with a full clinic licence to ... in business since 2007 helping people prevent and reverse heart disease through ...
    (Date:8/28/2015)... ... August 28, 2015 , ... Super-Sod launched their new website this ... most notable change is the responsive web design. Website users will now have an ... submit quote requests for sod, sign-up for the monthly turf-tips email, and find a ...
    Breaking Medicine News(10 mins):Health News:Medical Solutions Recognized as One of 2015 Best Places to Work in Healthcare 2Health News:Medical Solutions Recognized as One of 2015 Best Places to Work in Healthcare 3Health News:Non-surgical Treatment to Get Rid of The "Double Chin," Kybella™, Now Available at the Quatela Center for Plastic Surgery 2Health News:Non-surgical Treatment to Get Rid of The "Double Chin," Kybella™, Now Available at the Quatela Center for Plastic Surgery 3Health News:WEDI's The Sullivan Institute for Healthcare Innovation Releases Gaps in Care Survey 2Health News:Buy New External Counterpulsation (EECP or ECP) With Heart Fit Clinic 2
    ... a biological sciences major, earned first place at ... a poster presentation about proteins in the smooth ... muscle. The presentation was titled, "Modulation of Cardiovascular ... Metabolites." Tri-Beta is the national biological sciences honor ...
    ... (embargoed until June 11, 2008, 1:00 p.m. ET) Researchers ... Center have found that Smad proteins regulate microRNA (miRNA) ... to investigate abnormal miRNA processing which is a contributing ... study was published online today in Nature . ...
    ... Patients Model Top Designers Summer Ware on the ... Makeover Patients To Enjoy "Coming Out in Designer" Party, ... patients of New,York area doctors wearing the world,s top ... surgery fashion show and expo tomorrow,Thursday, June 12th, 2008 ...
    ... 2008: Systemic lupus erythematosus (SLE) patients with a ... severe disease manifestations, according to new research presented today ... League Against Rheumatism in Paris, France. , According ... is shown to be associated with the relatively milder ...
    ... YORK, June 11 WallSt.net,s 3-Minute Press Show is ... Shows air Monday through Friday on: http://tv.wallst.net ... with,public company executives on their company and most recent ... insight into a company,s most,recent press release, and its ...
    ... Outreach Foundation formed to raise awareness and educate ... public on first aid for seizures, ... (AEOF), epilepsyoutreach.org, has joined forces with,Hunter Tylo of CBS, The Bold ... disorders and to educate the public on first-aid,tips for someone experiencing ...
    Cached Medicine News:Health News:Need microRNA processing? Get Smad 2Health News:Lupus more severe in patients with Southern European ancestry 2Health News:[video] WallSt.net's '3 Minute Press Show' Features Executive Interviews and Highlights Recent Press for the Following: IUSA, IFUE, FEED, RXEI, GMPM, CRCUF, CVSC, GNMT 2Health News:[video] WallSt.net's '3 Minute Press Show' Features Executive Interviews and Highlights Recent Press for the Following: IUSA, IFUE, FEED, RXEI, GMPM, CRCUF, CVSC, GNMT 3Health News:Hunter Tylo of CBS' The Bold and The Beautiful Joins Forces With the American Epilepsy Outreach Foundation in Public Awareness Campaign 2Health News:Hunter Tylo of CBS' The Bold and The Beautiful Joins Forces With the American Epilepsy Outreach Foundation in Public Awareness Campaign 3
    ... A fixed pipette is ... a single volume. Fixed volume ... and advantages as other Finnpipette ... design, Super blow-out (1-40ul), Soft-touch ...
    Pipetman F is a fixed-volume, air-displacement pipette. Thirteen robust models cover a large volume range from 2 L to 1000 L, with Gilsons legendary accuracy and precision....
    ... Finnpipette Focus from Thermo Labsystems ... ergonomics with uncompromising performance. ... offers a custom fit for ... shorter tip cones allow easier ...
    ... A fixed pipette is ... a single volume. Fixed volume ... and advantages as other Finnpipette ... design, Super blow-out (1-40ul), Soft-touch ...
    Medicine Products: